Swan N Thung

Author PubWeight™ 83.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res 2008 4.35
2 Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 2004 3.00
3 Robust cellular reprogramming occurs spontaneously during liver regeneration. Genes Dev 2013 2.96
4 HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003 2.89
5 Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology 2011 2.66
6 Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 2013 2.42
7 A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology 2006 2.32
8 Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology 2004 2.29
9 Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am J Physiol Endocrinol Metab 2003 2.06
10 Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation. J Hepatol 2006 1.98
11 A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 2009 1.90
12 Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes 2002 1.87
13 Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. J Infect Dis 2008 1.78
14 Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. Liver Transpl 2008 1.68
15 Beyond "cirrhosis": a proposal from the International Liver Pathology Study Group. Am J Clin Pathol 2012 1.65
16 Pre-S2 deletion mutants of hepatitis B virus could have an important role in hepatocarcinogenesis in Asian children. Cancer Sci 2009 1.61
17 Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 2004 1.51
18 Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis 2011 1.46
19 Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology 2005 1.44
20 Retracted Metabolic basis of sexual dimorphism in PKU mice after genome-targeted PAH gene therapy. Mol Ther 2007 1.25
21 Immunohistochemical evidence for hepatic progenitor cells in liver diseases. Liver 2002 1.23
22 Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation. Mod Pathol 2010 1.11
23 Morphologic features of extrahepatic manifestations of hepatitis C virus infection. Clin Dev Immunol 2012 1.04
24 T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 2007 1.03
25 Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation. Liver Int 2005 0.99
26 Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2005 0.97
27 Basal insulin gene expression significantly improves conventional insulin therapy in type 1 diabetic rats. Diabetes 2002 0.95
28 Prophylactic alpha interferon treatment increases the therapeutic index of oncolytic vesicular stomatitis virus virotherapy for advanced hepatocellular carcinoma in immune-competent rats. J Virol 2005 0.95
29 Hepatic cavernous hemangioma: underrecognized associated histologic features. Liver Int 2006 0.95
30 Expression of human telomerase reverse transcriptase in regenerative and precancerous lesions of cirrhotic livers. Liver 2002 0.92
31 Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction. Semin Liver Dis 2011 0.91
32 Destruction of canals of Hering in primary biliary cirrhosis. Hum Pathol 2002 0.91
33 Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant. Liver Transpl 2009 0.90
34 Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries. Jpn J Infect Dis 2003 0.88
35 Fulminant hepatic failure attributed to ackee fruit ingestion in a patient with sickle cell trait. Case Rep Transplant 2012 0.87
36 Cholangiolocellular carcinoma in a pediatric patient with small duct sclerosing cholangitis: a case report. Semin Liver Dis 2013 0.87
37 Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature. Am J Surg Pathol 2011 0.87
38 Hepatocellular carcinoma associated with an atypical presentation of Wilson's disease. Semin Liver Dis 2007 0.87
39 Drug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone use. Semin Liver Dis 2009 0.86
40 Hepatocellular carcinoma and congenital absence of the portal vein in a child receiving growth hormone therapy for turner syndrome. Semin Liver Dis 2007 0.86
41 Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification. Int J Hepatol 2013 0.86
42 Acute and chronic hepatitis. Semin Diagn Pathol 2007 0.85
43 Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing. Hepatology 2012 0.85
44 Primary hepatic signet ring cell neuroendocrine tumor: a case report with literature review. Semin Liver Dis 2010 0.84
45 Methotrexate therapy for primary biliary cirrhosis. Am J Gastroenterol 2003 0.84
46 gC1qR expression in normal and pathologic human tissues: differential expression in tissues of epithelial and mesenchymal origin. J Histochem Cytochem 2012 0.84
47 Histopathologic manifestations of drug-induced hepatotoxicity. Clin Liver Dis 2013 0.83
48 Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis. Am J Surg Pathol 2007 0.82
49 Jaundice accompanied by giant cell hepatitis and eosinophilia in childhood. Semin Liver Dis 2004 0.82
50 Results of retransplantation for recurrent hepatitis C. Hepatology 2003 0.82
51 Epstein-Barr virus and human hepatocellular carcinoma. Cancer Lett 2003 0.82
52 Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation. Transplantation 2015 0.82
53 Outcomes following resection of intrahepatic cholangiocarcinoma. HPB (Oxford) 2014 0.81
54 Autoimmune cholangitis in the SJL/J mouse is antigen non-specific. Dev Immunol 2002 0.81
55 Malignant liver tumors. Clin Liver Dis 2002 0.80
56 Bile duct paucity in infancy. Semin Liver Dis 2007 0.79
57 Hepatitis C virus and malignancy. Hepatol Res 2007 0.78
58 Hepatic progenitor cells in liver cancers from Asian children. Liver Int 2009 0.78
59 Multiple inflammatory and serum amyloid A positive telangiectatic hepatic adenomas with glycogenated nuclei arising in a background of nonalcoholic steatohepatitis. Semin Liver Dis 2008 0.77
60 Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. Int J Hepatol 2013 0.77
61 Surgical resection of pulmonary metastases after orthotopic liver transplantation for hepatocellular carcinoma. Transplantation 2002 0.77
62 Molecular signature of early hepatocellular carcinoma. Oncology 2010 0.77
63 Intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver. Hum Gene Ther 2002 0.77
64 Histopathology and clinical correlates of end-stage hepatitis B cirrhosis: a possible mechanism to explain the response to antiviral therapy. Liver Transpl 2005 0.76
65 Hepatocellular proliferation and changes in microarchitecture of right lobe allografts in adult transplant recipients. Liver Transpl 2004 0.76
66 Coexistence of inflammatory hepatocellular adenomas with HNF1α-inactivated adenomas: is there an association? Histopathology 2014 0.76
67 A two-step right hepatic lobectomy with portal vein ligation for large hepatocellular carcinoma: rapid induction of left-lobe regeneration and clinicopathologic correlation. Semin Liver Dis 2013 0.76
68 Recurrent giant hemangiomas of liver: Report of two rare cases with literature review. World J Gastrointest Surg 2012 0.75
69 Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study. Hepatol Res 2009 0.75
70 A maxed-out liver: a case of acute-on-chronic liver failure. Semin Liver Dis 2011 0.75
71 Telangiectatic hyperplastic nodule associated with vascular malformation in a patient with chronic hepatitis B: radiologic and pathologic features. Semin Liver Dis 2013 0.75
72 Steatohepatitis secondary to long-term glucocorticoid treatment for congenital adrenal hyperplasia: a potential diagnostic pitfall. Semin Liver Dis 2013 0.75